Ligand Pharmaceuticals Incorporated
Profit History
| Fiscal Year | Revenue | Operating Income | Net Income |
|---|---|---|---|
| FY2009 | $38.9M | $-10.0M | $-1.9M |
| FY2010 | $23.5M | $-29.3M | $-10.4M |
| FY2011 | $30.0M | $-878.0K | $9.7M |
| FY2012 | $31.4M | $193.0K | $-527.0K |
| FY2013 | $49.0M | $14.9M | $11.4M |
| FY2014 | $64.5M | $19.6M | $12.0M |
| FY2015 | $71.9M | $27.3M | $229.8M |
| FY2016 | $109.0M | $43.9M | $-1.6M |
| FY2017 | $141.1M | $68.1M | $12.6M |
| FY2018 | $251.5M | $163.7M | $143.3M |
| FY2019 | $120.3M | $807.1M | $629.3M |
| FY2020 | $163.6M | $37.5M | $-3.0M |
| FY2021 | $241.5M | $103.9M | $57.1M |
| FY2022 | $196.2M | $3.0M | $-33.4M |
| FY2023 | $131.3M | $11.9M | $52.2M |
| FY2024 | $167.1M | $-22.6M | $-4.0M |
| FY2025 | $268.1M | $41.0M | $124.5M |